In AD, the typical lumbar CSF biomarker pattern comprises reduced Aβ42 and a low Aβ42/40 ratio, increased T-tau, P-tau and neurogranin, compared to controls [9, 12]. The gene discussed is MAPT; the disease is Alzheimer disease.